DPP4 and rheumatoid arthritis: Population-wide studies in the USA, UK, and Taiwan have shown that antidiabetic drugs such as biguanides and dipeptidyl peptidase-4 inhibitors, which improve insulin sensitivity, are associated with a reduced risk of RA [42,43,44].